Allogeneic memory-like natural killer (NK) cell therapy with IL-15 superagonist with or without ipilimumab for advanced, incurable head and neck cancer: A phase 1 trial

被引：0
|
作者：
Hanna, Glenn J.
Shapiro, Roman M.
Sheffer, Michal
Ansuinelli, Michela
Birch, Grace
Redd, Robert A.
Alonso, Alejandro
Bat-Erdene, Denbaa
Himberg, Samantha
Daley, Heather
Hernandez-Rodriquez, Diego E.
Shaw, Katharin L.
Ritz, Jerome
Nikiforow, Sarah
Soiffer, Robert J.
Romee, Rizwan
机构：
来源：
CLINICAL CANCER RESEARCH | 2023年 / 29卷 / 18期
关键词：
D O I：
10.1158/1557-3265.AACRAHNS23-PR11
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PR11
引用
收藏
页数：3
相关论文
共 17 条
  • [1] A phase 1 trial of cytokine-induced memory-like (CIML) natural killer (NK) cell therapy with IL-15 superagonist in advanced head and neck cancer: Part 1 results.
    Hanna, Glenn J.
    Coleman, Kimberly
    Birch, Grace
    Redd, Robert A.
    Alonso, Alejandro
    Bednarz, Samantha
    Daley, Heather
    Rodriguez, Diego E. Hernandez
    Shaw, Kit L.
    Haddad, Robert I.
    Uppaluri, Ravindra
    Ritz, Jerome
    Nikiforow, Sarah
    Soiffer, Robert J.
    Romee, Rizwan
    CANCER RESEARCH, 2022, 82 (12)
  • [2] First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer
    Shapiro, Roman M.
    Sheffer, Michal
    Booker, Matthew A.
    Tolstorukov, Michael Y.
    Birch, Grace C.
    Sade-Feldman, Moshe
    Fang, Jacy
    Li, Shuqiang
    Lu, Wesley
    Ansuinelli, Michela
    Dulery, Remy
    Tarannum, Mubin
    Baginska, Joanna
    Dwivedi, Nishant
    Kothari, Ashish
    Penter, Livius
    Abdulhamid, Yasmin Z.
    Kaplan, Isabel E.
    Khanhlinh, Dinh
    Uppaluri, Ravindra
    Redd, Robert A.
    Nikiforow, Sarah
    Koreth, John
    Ritz, Jerome
    Wu, Catherine J.
    Soiffer, Robert J.
    Hanna, Glenn J.
    Romee, Rizwan
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2025, 18 (01)
  • [3] CTLA-4 Blockade Results in the Enrichment of Proliferative CD56 dimCD16+NK Cells Following Infusion of Haploidentical Donor Memory-like Natural Killer Cells Plus IL-15 Superagonist in a Phase 1 Trial
    Shapiro, Roman M.
    Sheffer, Michal
    Booker, Matthew Aaron
    Tolstorukov, Michael Yevgeniy
    Ansuinelli, Michela
    Sade-Feldman, Moshe
    Fang, Jacy
    Birch, Grace Caroline
    Vergara-Cadavid, Juliana
    Abdulhamid, Yasmin Z.
    Kaplan, Isabel E.
    Khanhlinh, Dinh
    Redd, Robert A.
    Alonso, Alejandro
    Bat-Erdene, Denbaa
    Uppaluri, Ravindra
    Daley, Heather
    Rodriguez, Diego Hernandez
    Koreth, John
    Ritz, Jerome
    Nikiforow, Sarah
    Soiffer, Robert J.
    Hanna, Glenn J.
    Romee, Rizwan
    BLOOD, 2023, 142
  • [4] Memory-like differentiation, tumor targeting monoclonal antibodies, and chimeric antigen receptors enhance natural killer cell responses to head and neck cancer
    Jacobs, Miriam T.
    Wong, Pamela
    Zhou, Alice
    Becker-Hapak, Michelle
    Marin, Nancy
    Marsala, Lynne
    Foster, Mark
    Foltz, Jennifer
    Cubitt, Celia
    Tran, Jennifer
    Neal, Carly
    Russler-Germain, David
    Chang, Lily
    Schappe, Timothy
    McClain, Ethan
    Kersting-Schadek, Samantha
    DeSelm, Carl
    Berrien-Elliott, Melissa
    Puram, Sidarth V.
    Fehniger, Todd A.
    CANCER RESEARCH, 2023, 83 (07)
  • [5] Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer
    Jacobs, Miriam T.
    Wong, Pamela
    Zhou, Alice Y.
    Becker-Hapak, Michelle
    Marin, Nancy D.
    Marsala, Lynne
    Foster, Mark
    Foltz, Jennifer A.
    Cubitt, Celia C.
    Tran, Jennifer
    Russler-Germain, David A.
    Neal, Carly
    Kersting-Schadek, Samantha
    Chang, Lily
    Schappe, Timothy
    Pence, Patrick
    McClain, Ethan
    Zevallos, Jose P.
    Rich, Jason T.
    Paniello, Randal C.
    Jackson, Ryan S.
    Pipkorn, Patrik
    Adkins, Douglas R.
    DeSelm, Carl J.
    Berrien-Elliott, Melissa M.
    Puram, Sidharth V.
    Fehniger, Todd A.
    CLINICAL CANCER RESEARCH, 2023, 29 (20) : 4196 - 4208
  • [6] Combination therapy with IL-15 superagonist (ALT-803) and PD-1 blockade enhances human NK cell immunotherapy against ovarian cancer
    Geller, M. A.
    Bendzick, L. A.
    Ryan, C.
    Chu, S.
    Lenvik, A.
    Skubitz, A. P. N.
    Boylan, K. L. M.
    Vogel, R. Isaksson
    Miller, J.
    Felices, M.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 19 - 19
  • [7] Overall survival in patients with metastatic or locally advanced pancreatic cancer following chemoradiation with novel combination of aldoxorubicin, N-803 IL-15 superagonist, and PDL1-NK cell therapy.
    Seery, Tara Elisabeth
    Nangia, Chaitali Singh
    Reid, Phillip D.
    Fang, Bruno
    McKean, Heidi Ann
    Sender, Leonard S.
    Reddy, Sandeep K.
    Soon-Shiong, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 720 - 720
  • [8] A phase I trial of adoptive transfer of allogeneic natural killer (NK) cells in patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Iliopoulou, E. G.
    Kountourakis, P.
    Karamouzis, M. V.
    Doufexis, D.
    Ardavanis, A.
    Baxevanis, C. N.
    Rigatos, G.
    Papamichail, M.
    Perez, S. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients
    Seery, Tara
    Sender, Lennie
    Jafari, Omid
    Jones, Frank
    Spilman, Patricia
    Reddy, Sandeep B.
    Soon-Shiong, Patrick
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [10] In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Ali, Ayesha S.
    Manukian, Gregor
    Johnson, Jennifer M.
    Vathiotis, Ioannis
    Axelrod, Rita
    Keith, Scott W.
    Curry, Joseph
    Cognetti, David
    Luginbuhl, Adam
    Argiris, Athanassios
    Bar-Ad, Voichita
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (01): : 181 - 185
12